Sodium (±)‐5‐bromo‐2‐(α‐hydroxypentyl) benzoate ameliorates pressure overload‐induced cardiac hypertrophy and dysfunction through inhibiting autophagy

Sodium (±)‐5‐bromo‐2‐(a‐hydroxypentyl) benzoate (generic name: brozopine, BZP) has been reported to protect against stroke‐induced brain injury and was approved for Phase II clinical trials for treatment of stroke‐related brain damage by the China Food and Drug Administration (CFDA). However, the ro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cell Mol Med
Autori principali: Wang, Bo, Shen, Deliang, Tang, Junnan, Li, Jing, Xiao, Yue, Chen, Xiuying, Cao, Chang, Han, Dongjian, Gao, Erhe, Zhao, Wen, Zhang, Jinying, Chang, Junbiao
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714213/
https://ncbi.nlm.nih.gov/pubmed/31222939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14468
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi